Thank you to all for making Tuesday a special evening! CSOFT’s sponsored V.I.P. Social at the elegant Empire Restaurant Boston was a large success. We welcomed guests from around the world within the medical industry. The evening’s cuisine was paired with smooth Jazz and great conversation. All of it was made possible by our wonderful […]
On September 23-25th, CSOFT will be attending the Medtech Conference in Boston along with 3,000 other attendees to network and share insight with medical technology industry leaders. Attendees will have the opportunity to witness more than 300 speakers discuss topics pertinent to today’s medical technology industry such as the increasing use of artificial intelligence, regulations […]
Our 15th Annual Summit: Global Leaders Networking event will focus on a variety of life science industry topics. Leading executives & experts from sectors such as MedTech, pharma, and diagnostics will be hosting afternoon sessions at the Boston Public Library’s ornate Courtyard Tea Room, sharing their expertise on how to expand life science products and services internationally.
On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.
From May 23-25, CSOFT’s MedL10N Life Sciences Unit attended and exhibited at the 10th DIA China Conference held at the Beijing International Convention Center. This year’s event attracted thousands of pharmaceutical R&D professionals from around the world to discuss new drug regulations, drug research and development, and the future of the health care industry in China.